Thrive Capital Management (Pennsylvania)’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$400K Sell
1,914
-28
-1% -$5.54K 0.08% 138
2026
Q1
$320K Sell
1,942
-4
-0.2% -$693 0.07% 142
2025
Q4
$345K Buy
1,946
+115
+6% +$19.2K 0.08% 144
2025
Q3
$291K Sell
1,831
-164
-8% -$24.2K 0.08% 153
2025
Q2
$281K Buy
+1,995
New +$245K 0.09% 147
2024
Q1
Sell
-2,410
Closed -$225K 177
2023
Q4
$225K Buy
+2,410
New +$193K 0.12% 135

Other funds holding MS

Thrive Capital Management (Pennsylvania)'s MS Position: Q2 2026 in Review

Thrive Capital Management (Pennsylvania) reduced its Morgan Stanley (MS) stake by 1.4% in Q2 2026, selling an estimated $5.54K and leaving 1,914 shares worth $400K. The position accounts for 0.08% of the portfolio, ranked #138.

Thrive Capital Management (Pennsylvania) first reported a position in MS in Q4 2023 and has held it in 6 quarters since. 2,725 funds tracked by Wall St. Rank hold MS as of Q2 2026.

  • Thrive Capital Management (Pennsylvania) held 1,914 shares of Morgan Stanley worth $400K as of Q2 2026.
  • Thrive Capital Management (Pennsylvania) sold 28 Morgan Stanley shares in Q2 2026, an estimated $5.54K.
  • Morgan Stanley made up 0.08% of Thrive Capital Management (Pennsylvania)'s portfolio in Q2 2026, its #138 holding.
  • Thrive Capital Management (Pennsylvania) first reported a position in Morgan Stanley in Q4 2023 and has held it in 6 quarters since.
  • 2,725 funds tracked by Wall St. Rank held Morgan Stanley as of Q2 2026.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q2 2026, filed 5 Aug 2026.